EKB Technology Ltd Raises £325,000
EKB Technology Ltd, provider of a completely new and patent pending bioprocessing technology, has been successful in raising £325,000 from the Oxford Technology 4 Venture Capital Trust.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
EKB Technology Ltd, provider of a completely new and patent pending bioprocessing technology, has been successful in raising £325,000 from the Oxford Technology 4 Venture Capital Trust.
Third Phase Limited, a high-tech company spun out from Oxford University's Department of Engineering Science and now based on the Cambridge Science Park, is pleased to announce that it has merged with the Cmed Group Ltd, opening up tremendous development opportunities for both companies.
OxLoc today announced changes to its Board of Directors so as to support the Company’s rapid commercial progress of its novel, battery-powered asset tracking technology. As of 1 st August 2005, Daniel Burnett, currently a non-executive director will become Non Executive Chairman of OxLoc.
Oxford Immunotec, the T cell diagnostics company, announced today that it has closed a £7M series B private equity financing.
Devices Enable 24-hour Monitoring of Non-Powered Assets, Increased Asset Utilization and Efficiency, Visible Asset Management, Improved Security, and Minimized Theft/Damage/Loss for up to 3 years
A new spin-out from Oxford University, Spinox, is aiming to devise novel ways to copy spiders' ability to spin silks. The new silks may be used for sutures or woven material for surgical implants, protective clothing and in sports equipment.
Oxitec Ltd is pleased to announce that it is a member of a consortium that has been offered funding to develop new genetic strategies for control of dengue virus.
Oxitec Limited announces the completion of its second funding round of £1.3m, led by Oxford Capital Partners. The existing investors, East Hill Advisors, LLC from Boston and the University of Oxford (through the Isis College Fund), have made further investments in the company as part of this round. Oxford Capital Partners invested £550,000.
BioAnalab Limited, the Oxford-based specialist contract analytical laboratory, today announced the successful completion of a further round of private equity funding totalling £440,000. The round was led by Octopus Asset Management, who invested £250,000 through the BioScience Venture Capital Trust.
IP2IPO Group plc (AIM: IPO) ("IP2IPO"), the intellectual property company that specialises in commercialising university technology, is pleased to announce that it has acquired a stake of 44.3% in Oxford NanoLabs Limited ("ONL"), a spin-out company from the Chemistry Department at the University of Oxford.